<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00273221</url>
  </required_header>
  <id_info>
    <org_study_id>DSRB-A/05/196</org_study_id>
    <nct_id>NCT00273221</nct_id>
  </id_info>
  <brief_title>Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled Trial</brief_title>
  <official_title>Combined Phacoemulsification and Glaucoma Implant Surgery Versus Combined Phacoemulsification and Trabeculectomy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effectiveness and safety of combined&#xD;
      phacoemulsification, posterior chamber intraocular lens implantation , trabeculectomy&#xD;
      (phacotrabeculectomy) with phacoemulsification, intraocular lens implantation and glaucoma&#xD;
      drainage device(phacotube) in the early and intermediate control of intraocular pressure(IOP)&#xD;
      in patients with primary open angle and angle closure glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies have pointed out racial differences in the outcome of conventional filtration&#xD;
      surgery. Glaucoma drainage implants have been found to do well in Asian eyes but no&#xD;
      randomized controlled trial is available to support this claim. Objectives: It is the aim of&#xD;
      this study to compare the effectiveness and safety of combined phacoemulsification, posterior&#xD;
      chamber intraocular lens implantation , trabeculectomy (phacotrabeculectomy) versus&#xD;
      phacoemulsification, intraocular lens implantation and glaucoma drainage device(phacotube) in&#xD;
      the early and intermediate control of intraocular pressure(IOP) in patients with primary open&#xD;
      angle and angle closure glaucoma. The secondary objective is to look into the post-operative&#xD;
      complications encountered in phacotrabeculectomy and phacotube including the additional&#xD;
      interventions (laser suture lysis, bleb needling, antimetabolite injections, etc.) applied in&#xD;
      both procedures being studied Study Design. Randomized controlled trial. Methods. A total of&#xD;
      50 Asian subjects, 21 years old and above diagnosed with primary open/angle closure glaucoma,&#xD;
      inadequately controlled by laser and medical treatment, with significant cataract and no&#xD;
      previous eye surgery will be randomized to two types of combined procedures,&#xD;
      phacotrabeculectomy and phacotube. Primary outcome measure is intraocular pressure and&#xD;
      secondary outcome measures will be visual acuity, anterior chamber depth, visual field&#xD;
      stability or progression, glaucoma medication requirement, operative and post-operative&#xD;
      complications and additional, secondary interventions(e.g. laser suture lysis, bleb needling,&#xD;
      5-FU injections, anterior chamber reformation). All subjects will be followed up for a period&#xD;
      of 1 year.This trial may define the role of GDI as a primary surgical option for Asian&#xD;
      patients and the first randomized clinical trial in Asia to compare two combined procedures&#xD;
      for glaucoma and cataract namely phacotrabeculectomy and phaco-glaucoma drainage implant&#xD;
      surgery.﷡&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <completion_date type="Anticipated">July 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraocular pressure(IOP).</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual acuity,anterior chamber depth,visual field, glaucoma medication requirement, operative and post-operative complications and additional interventions(e.g.laser suture lysis, bleb</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glaucoma</condition>
  <condition>Cataract</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Glaucoma Implant Surgery</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trabeculectomy</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Ø 21 years old and above Ø Primary Open Angle Glaucoma with Shaffer grade 2 or better for&#xD;
        360 degrees Ø Primary Angle Closure Glaucoma (occludable angles +/- PAS) Ø Inadequate IOP&#xD;
        control despite maximum medical treatment (using at least 2 types or more antiglaucoma&#xD;
        medications) and/or laser treatment in the presence of glaucomatous optic neuropathy on&#xD;
        optic nerve head evaluation and corresponding visual field findings Ø Visually significant&#xD;
        cataract with visual acuity of less than or equal to 6/12 Ø No corneal disease Ø Willing to&#xD;
        be followed up for 1 year duration post-operatively Ø Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ø Secondary Glaucoma (Uveitic, Neovascular, traumatic, Iridocorneal Endothelial&#xD;
             Syndrome); Congenital Glaucoma Ø Severe ocular disease like Proliferative Diabetic&#xD;
             Retinopathy, Age-related Macular Degeneration Exudative type Ø Prior intraocular&#xD;
             surgery(in the study eye) Ø Patients with small central island and temporal field&#xD;
             remaining on perimetry Ø One-eyed patients or fellow eye with visual acuity of&#xD;
             counting fingers (CF) or worse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul TC Chew, A/Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul TC Chew, A/Prof.</last_name>
    <phone>67725317</phone>
    <phone_ext>5317</phone_ext>
    <email>ophchew@nus.edu.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Cecilia D Aquino, MD</last_name>
    <phone>67725317</phone>
    <phone_ext>5317</phone_ext>
    <email>cel_aq@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>5 Lower Kent Ridge Road</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul TC Chew, A/Professor</last_name>
      <phone>67725317</phone>
      <phone_ext>5317</phone_ext>
      <email>ophchew@nus.edu.sg</email>
    </contact>
    <contact_backup>
      <last_name>Maria Cecilia D Aquino, MD</last_name>
      <phone>67725317</phone>
      <phone_ext>5317</phone_ext>
      <email>cel_aq@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Paul TC Chew, A/Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Cecilia D Aquino, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jovina L See, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Winifred Patricia Nolan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <study_first_submitted>January 6, 2006</study_first_submitted>
  <study_first_submitted_qc>January 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2006</study_first_posted>
  <last_update_submitted>May 21, 2008</last_update_submitted>
  <last_update_submitted_qc>May 21, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2008</last_update_posted>
  <keyword>Glaucoma</keyword>
  <keyword>Cataract</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

